Zacks Investment Research upgraded shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) from a sell rating to a buy rating in a research note released on Wednesday. They currently have $21.00 price target on the stock.

According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “

Several other equities research analysts have also recently commented on the company. J P Morgan Chase & Co reaffirmed a neutral rating on shares of Reckitt Benckiser Group PLC in a research report on Thursday, September 7th. BNP Paribas reaffirmed a neutral rating on shares of Reckitt Benckiser Group PLC in a research report on Tuesday, September 5th. Kepler Capital Markets cut Reckitt Benckiser Group PLC from a buy rating to a hold rating in a research report on Wednesday, July 26th. Jefferies Group LLC cut Reckitt Benckiser Group PLC from a buy rating to a hold rating in a research report on Thursday, July 6th. Finally, Societe Generale reissued a hold rating on shares of Reckitt Benckiser Group PLC in a research report on Thursday, June 22nd. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of Hold and an average target price of $21.00.

Shares of Reckitt Benckiser Group PLC (OTCMKTS RBGLY) traded down 0.75% during trading on Wednesday, hitting $18.45. 36,386 shares of the company were exchanged. The stock has a market capitalization of $64.89 billion, a PE ratio of 27.46 and a beta of 0.86. Reckitt Benckiser Group PLC has a 1-year low of $16.36 and a 1-year high of $21.55. The company has a 50 day moving average of $19.28 and a 200-day moving average of $19.49.

ILLEGAL ACTIVITY WARNING: “Reckitt Benckiser Group PLC (RBGLY) Upgraded by Zacks Investment Research to Buy” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.watchlistnews.com/reckitt-benckiser-group-plc-rbgly-upgraded-by-zacks-investment-research-to-buy/1594075.html.

The company also recently announced a None dividend, which will be paid on Thursday, October 5th. Shareholders of record on Friday, August 18th will be given a $0.163 dividend. The ex-dividend date of this dividend is Wednesday, August 16th.

Reckitt Benckiser Group PLC Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group PLC (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.